Main Article Content
Background: Pulmonary embolism (PE) is a major cause of morbidity and mortality worldwide, and has significant negative impacts on quality of life, healthcare costs, and longevity. Registries have been created to record ‘real-life’ clinical features and management of patients with PE.
Aim: We aimed to describe a comprehensive view of the clinical presentation, demographic data, treatment modalities and short-term outcome at hospital discharge and 3 months after discharge for patients presented with acute pulmonary embolism at Tanta university hospital to improve the level of care of those patients.
Methods: This study was conducted on 150 patients with confirmed acute PE presented to Tanta university hospitals. The study duration was 1 year from April 2019 to May 2020.
Results: We focused on a group of common risk factors for PE and determined prevelance of each in our enrolled patients, we found increase some risk factors obesity and bed rest > 3 days were the most prevalent risk factors followed by active cancer, estrogen use and lower limb fracture. Symptoms in this study are near to other registries and ESC guidelines 2019 with the commonest symptom was dyspnea and chest pain and the least symptom was hemoptysis. Certain ECG signs more prevalent in our patients and these signs related to RV strain with sinus tachycardia the commonest sign followed by S1Q3T3 sign and the least was right axis deviation.
Conclusion: Presence of active cancer and patients with high risk stratification were independent predictors of mortality. Other factors associated with increased mortality were impaired RV systolic function, high PESI score, presence of RBBB in ECG and presence of congestive heart failure. Increased risk of bleeding in male patients with intermediate high or high risk category especially those received UFH and fibrinolytic therapy. Previous history of VTE was independent predictors of VTE recurrence.
Puengpapat S, Pirompanich P. Incidence of chronic thromboembolic pulmonary hypertension in Thammasat University Hospital. Lung India. 2018;35(5):373-378.
Marshall PS, Mathews KS, Siegel MD. Diagnosis and management of life-threatening pulmonary embolism. J Intensive Care Med. 2011:89.
Bajaj N, Bozarth AL, Guillot J, Kojokittah J, Appalaneni SR, Cestero C, et al. Clinical features in patients with pulmonary embolism at a community hospital: analysis of 4 years of data. J Thromb Thrombolysis. 2014;37(3):287-292.
Jiménez D, De Miguel-Díez J, Guijarro R, Trujillo-Santos J, Otero R, Barba R, et al. Trends in the management and outcomes of acute pulmonary embolism analysis from the RIETE registry. J Am Coll Cardiol. 2016;4(5):67.
Garvey S, Dudzinski DM, Giordano N, Torrey J, Zheng H, Kabrhel C. Pulmonary embolism with clot in transit: An analysis of risk factors and outcomes. Thromb Res. 2020;2(3):44.
Jiménez D, Bikdeli B, Barrios D, et al. Management appropriateness and outcomes of patients with acute pulmonary embolism. Eur Respir J. 2018;3(4):66.
Gussoni G, Frasson S, La Regina M, Di Micco P, Monreal M. Three-month mortality rate and clinical predictors in patients with venous thromboembolism and cancer. Findings from the RIETE registry. Thromb Res. 2013;3(2):124.
Casazza F, Becattini C, Bongarzoni A, Cuccia C, Roncon L, Favretto G, et al. Clinical features and short term outcomes of patients with acute pulmonary embolism. the Italian Pulmonary Embolism Registry (IPER). Thromb Res. 2012; 130(6):847-52.
Pollack CV, Schreiber D, Goldhaber SZ, Slattery D, Fanikos J, O'Neil BJ, et al. Clinical characteristics, management, and outcomes of patients diagnosed with acute pulmonary embolism in the emergency department: Initial report of EMPEROR (multicenter emergency medicine pulmonary embolism in the real world registry). J Am Coll Cardiol. 2011;57(6):700-6.
Fairweather DL, Rose NR. Women and autoimmune diseases. In: Emerging Infectious Diseases. 2004;174.
Chuang LH, Gumbs P, Van Hout B, Agnelli G, Kroep S, Monreal M, et al. Health-related quality of life and mortality in patients with pulmonary embolism: a prospective cohort study in seven European countries. Qual Life Res. 2019;28(8):2111-2124.
Yamashita Y, Morimoto T, Amano H, Takase T, Hiramori S, Kim K, et al. Deep vein thrombosis in upper extremities: Clinical characteristics, management strategies and long-term outcomes from the COMMAND VTE Registry. Thromb Res. 2019;177:1-9.
Shopp JD, Stewart LK, Emmett TW, Kline JA. Findings from 12-lead electrocardiography that predict circulatory shock from pulmonary embolism: Systematic review and meta-analysis. Acad Emerg Med. 2015;24(34):367.
Kukla P, Kosior DA, Tomaszewski A, Ptaszyńska-Kopczyńska K, Widejko K, Długopolski R, et al. Correlations between electrocardiogram and biomarkers in acute pulmonary embolism: Analysis of ZATPOL-2 Registry. Ann Noninvasive Electrocardiol. 2017;3(5):59.
Holder T, Sullivan AE, Truong T, Patel MR, Sofela O, Green CL, et al. Identification, diagnosis, treatment, and in-hospital outcomes of acute pulmonary embolism: Results from a single integrated health system. Am Heart J. 2019;216:136-142.
Yamashita Y, Murata K, Morimoto T, Amano H, Takase T, Hiramori S, et al. Clinical outcomes of patients with pulmonary embolism versus deep vein thrombosis: From the COMMAND VTE Registry. Thromb Res. 2019;184:50-57.
Zhou XY, Ben SQ, Chen HL, Ni SS. The prognostic value of pulmonary embolism severity index in acute pulmonary embolism: A meta-analysis. Respir Res. 2012;14(22):234.
Bundhun PK, Janoo G, Chen MH. Bleeding events associated with fibrinolytic therapy and primary percutaneous coronary intervention in patients with STEMI. Medicine (Baltimore). 2016; 6(4):134.